JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Breese, G. R.
Right arrow Articles by Traylor, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breese, G. R.
Right arrow Articles by Traylor, D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 174, Issue 3, 413-420, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF 6-HYDROXYDOPAMINE ON BRAIN NOREPINEPHRINE AND DOPAMINE: EVIDENCE FOR SELECTIVE DEGENERATION OF CATECHOLAMINE NEURONS

George R. Breese 1 and Dennis Traylor 1

1 Departments of Psychiatry and Pharmacology and the Child Development Institute, University of North Carolina School of Medicine, Chapel Hill, North Carolina

After the intracisternal administration of 6-hydroxydopamine, brain levels of norepinephrine were reduced significantly with or without pargyline pretreatment. Depletion of dopamine in the central nervous system was found to be enhanced markedly by pargyline administration at higher dose levels of 6-hydroxydopamine. Brain serotonin concentrations were not altered. The effects of 6-hydroxydopamine were long-lasting with the depletion of brain amines persisting at 78 days. After norepinephrine-H3 intracisternally to animals treated with 6-hydroxydopamine, labeled norepinephrine uptake was diminished with a corresponding reduction of deaminated catechols and a marked increased in methylated amines. Tyrosine hydroxylase activity was found to be reduced in brainstem, caudate nucleus and whole brain in 6-hydroxydopamine-treated animals. Conversion of tyrosine-H3 to labeled norepinephrine and dopamine was also markedly diminished. The results support the view that 6-hydroxydopamine produces a "central sympathectomy" when introduced into cerebrospinal fluid.

Submitted on October 27, 1969
Accepted on May 10, 1970




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Hanrott, L. Gudmunsen, M. J. O'Neill, and S. Wonnacott
6-Hydroxydopamine-induced Apoptosis Is Mediated via Extracellular Auto-oxidation and Caspase 3-dependent Activation of Protein Kinase C{delta}
J. Biol. Chem., March 3, 2006; 281(9): 5373 - 5382.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. S. Reynolds, R. J. Carter, and A. J. Morton
Dopamine Modulates the Susceptibility of Striatal Neurons to 3-Nitropropionic Acid in the Rat Model of Huntington's Disease
J. Neurosci., December 1, 1998; 18(23): 10116 - 10127.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Mailman, R. Ferris, F. Tang, R. Vogel, C. Kilts, M. Lipton, D. Smith, R. Mueller, and G. Breese
Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes?
Science, February 1, 1980; 207(4430): 535 - 537.
[Abstract] [PDF]


Home page
ScienceHome page
A. Acheson, M. Zigmond, and E. Stricker
Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine
Science, February 1, 1980; 207(4430): 537 - 540.
[Abstract] [PDF]


Home page
ScienceHome page
T Kasamatsu and J. Pettigrew
Depletion of brain catecholamines: failure of ocular dominance shift after monocular occlusion in kittens
Science, October 8, 1976; 194(4261): 206 - 209.
[Abstract] [PDF]


Home page
ScienceHome page
J. Ahlskog, P. Randall, and B. Hoebel
Hupothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons
Science, October 24, 1975; 190(4212): 399 - 401.
[PDF]


Home page
ScienceHome page
J. E. Ahlskog and B. G. Hoebel
Overeating and Obesity from Damage to a Noradrenergic System in the Brain
Science, October 12, 1973; 182(4108): 166 - 169.
[Abstract] [PDF]


Home page
ScienceHome page
H. S. Akiskal and W. T. McKinney Jr.
Depressive Disorders: Toward a Unified Hypothesis: Clinical, experimental, genetic, biochemical, and neurophysiological data are integrated
Science, October 5, 1973; 182(4107): 20 - 29.
[Abstract] [PDF]


Home page
ScienceHome page
D. E. Redmond Jr., R. L. Hinrichs, J. W. Maas, and A. Kling
Behavior of Free-Ranging Macaques after Intraventricular 6-Hydroxydopamine
Science, September 28, 1973; 181(4106): 1256 - 1258.
[Abstract] [PDF]


Home page
ScienceHome page
M. J. Ligmond and E. M. Stricker
Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats
Science, September 29, 1972; 177(4055): 1211 - 1214.
[Abstract] [PDF]


Home page
ScienceHome page
R. Heikiila and G. Cohen
Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine
Science, June 18, 1971; 172(3989): 1257 - 1258.
[Abstract] [PDF]


Home page
ScienceHome page
L. Stein and C. D. Wise
Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine
Science, March 12, 1971; 171(3975): 1032 - 1036.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.